Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Effect of sodium-glucose cotransporter-2 inhibitor (SGLT2-i) in patients with LVAD: a systematic review and meta-analysis

Event: ESC Congress 2024

Topic: Diuretics

Session: Diabetes, obesity, and the heart

Access
Like
Thumbnail

Associated factors and percentage of cardiac recovery among patients using LVAD: a meta-analysis of 31 studies

Event: ESC Congress 2024

Topic: Ventricular Assist Devices

Session: Heart transplantation, LVADs and inotropic support in heart failure: challenges and expectations

Access
Like
Thumbnail

Cardiac recovery and reverse remodeling in patients using LVAD: a systematic review and meta-analysis

Event: Heart Failure 2024

Topic: Ventricular Remodelling

Session: Acute, advanced and worsening heart failure: prognostic aspects

Access
Like
Thumbnail

Efficacy of ARNI in patients using LVAD: a systematic review and meta-analysis

Event: Heart Failure 2024

Topic: Angiotensin-Renin-Bradykinin System

Session: Pharmacology and pharmacotherapy

Access
Like
Thumbnail

Efficacy and safety of SGLT2-i in patients using LVAD: a systematic review and meta-analysis

Event: Heart Failure 2024

Topic: Diuretics

Session: Pharmacology and pharmacotherapy

Access
Like
Thumbnail

Left ventricular cardiac recovery and reverse remodeling in patients with aortic stenosis after TAVI: a systematic review and meta-analysis

Event: Heart Failure 2024

Topic: Aortic Valve Intervention

Session: Interventional cardiology

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources